Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Genova C, Tasso R, Rosa A, Rossi G, Reverberi D, Fontana V, Marconi S, Croce M, Dal Bello MG, Dellepiane C, Tagliamento M, Ciferri MC, Zullo L, Fedeli A, Alama A, Cortese K, Gentili C, Cella E, Anselmi G, Mora M, Barletta G, Rijavec E, Grossi F, Pronzato P, Coco S. Genova C, et al. Among authors: croce m. Cells. 2023 Mar 8;12(6):832. doi: 10.3390/cells12060832. Cells. 2023. PMID: 36980174 Free PMC article.
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.
Marconi S, Croce M, Chiorino G, Rossi G, Guana F, Profumo A, Ostano P, Alama A, Longo L, De Luca G, Dono M, Dal Bello MG, Ponassi M, Rosano C, Romano P, Cavalieri Z, Grassi M, Tagliamento M, Zullo L, Venturi C, Dellepiane C, Mastracci L, Bennicelli E, Pronzato P, Genova C, Coco S. Marconi S, et al. Among authors: croce m. Cancers (Basel). 2022 Jul 14;14(14):3412. doi: 10.3390/cancers14143412. Cancers (Basel). 2022. PMID: 35884472 Free PMC article.
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting.
Vanni I, Pastorino L, Tanda ET, Andreotti V, Dalmasso B, Solari N, Mascherini M, Cabiddu F, Guadagno A, Coco S, Allavena E, Bruno W, Pietra G, Croce M, Gangemi R, Piana M, Zoppoli G, Ferrando L, Spagnolo F, Queirolo P, Ghiorzo P. Vanni I, et al. Among authors: croce m. Int J Mol Sci. 2023 Feb 21;24(5):4302. doi: 10.3390/ijms24054302. Int J Mol Sci. 2023. PMID: 36901733 Free PMC article.
IL-27 Mediates PD-L1 Expression and Release by Human Mesothelioma Cells.
Carbotti G, Dozin B, Martini S, Giordano C, Scordamaglia F, Croce M, Filaci G, Ferrini S, Fabbi M. Carbotti G, et al. Among authors: croce m. Cancers (Basel). 2021 Aug 9;13(16):4011. doi: 10.3390/cancers13164011. Cancers (Basel). 2021. PMID: 34439164 Free PMC article.
How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma.
Marseglia M, Amaro A, Solari N, Gangemi R, Croce E, Tanda ET, Spagnolo F, Filaci G, Pfeffer U, Croce M. Marseglia M, et al. Among authors: croce m, croce e. Cancers (Basel). 2021 Apr 23;13(9):2043. doi: 10.3390/cancers13092043. Cancers (Basel). 2021. PMID: 33922591 Free PMC article. Review.
Immunotherapeutic applications of IL-15.
Croce M, Orengo AM, Azzarone B, Ferrini S. Croce M, et al. Immunotherapy. 2012 Sep;4(9):957-69. doi: 10.2217/imt.12.92. Immunotherapy. 2012. PMID: 23046239 Review.
577 results